Growth Inhibition of Mouse Skin Tumor by Serine Protease Inhibitor ONO-3403

    September 2001 in “ PubMed
    M Ohkoshi, Satoru Okuda
    TLDR ONO-3403 effectively reduces mouse skin tumor growth without side effects.
    The study investigated the effects of the serine protease inhibitor ONO-3403 on mouse skin tumors induced by 3-methylcholanthrene. ONO-3403, an analog of FOY-305, demonstrated significantly lower IC50 values against serine proteases like trypsin, plasmin, kallikrein, and thrombin compared to FOY-305. In the experiment, seven mice were administered ONO-3403 intraperitoneally at a dose of 4 mg/kg twice daily for 5 weeks. The treatment resulted in potent tumor growth suppression (p<0.001) without noticeable side effects such as hair loss or body weight loss. These findings suggested that ONO-3403 could be a potential treatment for squamous cell carcinoma.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 8 results

    Related Research

    1 / 1 results